TY - JOUR
T1 - Extracranial stereotactic radiation delivery
T2 - Expansion of technology beyond the brain
AU - Timmerman, Robert
AU - Papiez, Lech
AU - Suntharalingam, Mohan
PY - 2003/4
Y1 - 2003/4
N2 - The development of improved immobilization systems, and a greater understanding of the radiobiologic considerations associated with stereotactic radiotherapy has recently led to the clinical implementation of this technology to extracranial sites. The shared principles of targeting and treatment delivery has led to a greater understanding of the potential role this therapy may have in the management of extracranial disease. This article will review, the radiobiologic considerations and the basic principles of physics and dosimetry that help govern the utilization of extracranial stereotactic radiotherapy. In addition, this article will summarize the data that exists in the literature to date, that has documented the rationale, and efficacy of this novel therapeutic approach.
AB - The development of improved immobilization systems, and a greater understanding of the radiobiologic considerations associated with stereotactic radiotherapy has recently led to the clinical implementation of this technology to extracranial sites. The shared principles of targeting and treatment delivery has led to a greater understanding of the potential role this therapy may have in the management of extracranial disease. This article will review, the radiobiologic considerations and the basic principles of physics and dosimetry that help govern the utilization of extracranial stereotactic radiotherapy. In addition, this article will summarize the data that exists in the literature to date, that has documented the rationale, and efficacy of this novel therapeutic approach.
UR - http://www.scopus.com/inward/record.url?scp=0037992520&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037992520&partnerID=8YFLogxK
U2 - 10.1177/153303460300200212
DO - 10.1177/153303460300200212
M3 - Review article
C2 - 12680797
AN - SCOPUS:0037992520
SN - 1533-0346
VL - 2
SP - 153
EP - 160
JO - Technology in Cancer Research and Treatment
JF - Technology in Cancer Research and Treatment
IS - 2
ER -